The stark realities of antimicrobial resistance is Clear. Rising rates of difficult-to-treat infections, as well as
Covid 19 infections leave people more vulnerable to serious infections that are resistant to antibiotics. Anti-bacterial resistance remain urgent priorities, experts say.
For some patients, the pandemic and antimicrobial resistance (AMR) are intertwined.
A lack of new antimicrobials in development is not a new story. Most large pharmaceutical companies have left the area of anti-infectants and the bulk of research and development is now in small pharmaceutical companies, and they’re struggling to keep up with research costs.
Although some institutions shifted resources away from AMR out of necessity when COVID-19 struck, however, in some instances, treatments used to keep people with COVID-19 alive can paradoxically place them at higher risk for other infections.
Antimicrobial resistance is not just a problem for ICU patients in the hospital. As rates of resistance rise as these infections become more virulent, AMR is becoming more and more of a threat to society.
Furthermore, consumers are partially to blame as well. It’s interesting when you look at the surveys of the numbers of patients that self medicate and have used someone else’s antibiotics or leftover antimicrobial agents from a prior infection, that’s the sort of antibiotic overuse that directly contributes to antibacterial resistance.
To Avoid complications from the over use and inappropriate use of antibiotics please consult a doctor and follow the prescription. Always complete your dose of antibiotics even if you feel better.
